SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000913275-99-000022
Filing Date
1999-11-05
Accepted
1999-11-05 00:00:00
Documents
2
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED JUNE 30, 1999 0000913275-99-000022-d1.html 10-Q/A 40527
2 FINANCIAL DATA SCHEDULE EX-27.1 2578
  Complete submission text file 0000913275-99-000022.txt   44646
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-22570 | Film No.: 99741948
SIC: 2833 Medicinal Chemicals & Botanical Products